Cargando…

Impact of MIF Gene Promoter Polymorphism on F508del Cystic Fibrosis Patients

Macrophage migration Inhibitory Factor (MIF) is a pro-inflammatory cytokine sustaining the acute response to gram–negative bacteria and a regulatory role for MIF in Cystic Fibrosis has been suggested by the presence of a functional, polymorphic, four-nucleotide repeat in this gene's promoter at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melotti, Paola, Mafficini, Andrea, Lebecque, Patrick, Ortombina, Myriam, Leal, Teresinha, Pintani, Emily, Pepermans, Xavier, Sorio, Claudio, Assael, Baroukh Maurice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264759/ https://www.ncbi.nlm.nih.gov/pubmed/25503271 http://dx.doi.org/10.1371/journal.pone.0114274

Ejemplares similares

Challenging the diagnosis of Cystic Fibrosis in a patient carrying the 186-8T/C allelic variant in the CF Transmembrane Conductance Regulator gene
por: Caldrer, Sara, et al.
Publicado: (2014)

Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice
por: Legssyer, Rachida, et al.
Publicado: (2006)

Defective CFTR Expression and Function Are Detectable in Blood Monocytes: Development of a New Blood Test for Cystic Fibrosis
por: Sorio, Claudio, et al.
Publicado: (2011)

The GCC repeat length in the 5'UTR of MRP1 gene is polymorphic: a functional characterization of its relevance for cystic fibrosis
por: Nicolis, Elena, et al.
Publicado: (2006)

Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy
por: Cigana, Cristina, et al.
Publicado: (2016)

Revisiting the Role of Leukocytes in Cystic Fibrosis
por: Averna, Monica, et al.
Publicado: (2021)

Resveratrol increases F508del-CFTR dependent salivary secretion in cystic fibrosis mice
por: Dhooghe, Barbara, et al.
Publicado: (2015)

Cystic fibrosis transmembrane conductance regulator functional evaluations in a G542X+/- IVS8Tn:T7/9 patient with acute recurrent pancreatitis
por: Caldrer, Sara, et al.
Publicado: (2019)

Organoid Technology and Its Role for Theratyping Applications in Cystic Fibrosis
por: Conti, Jessica, et al.
Publicado: (2022)

Early diagnosis from newborn screening maximises survival in severe cystic fibrosis
por: Tridello, Gloria, et al.
Publicado: (2018)

When and how ruling out cystic fibrosis in adult patients with bronchiectasis
por: Gramegna, Andrea, et al.
Publicado: (2018)

Decoding F508del Misfolding in Cystic Fibrosis
por: Wang, Xiaodong Robert, et al.
Publicado: (2014)

Dysregulated Proinflammatory and Fibrogenic Phenotype of Fibroblasts in Cystic Fibrosis
por: Huaux, François, et al.
Publicado: (2013)

CFTR-F508 pigs provide new clues to cystic fibrosis
Publicado: (2011)

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
por: Schmidt, Béla Z, et al.
Publicado: (2016)

New insights into the Shwachman-Diamond Syndrome-related haematological disorder: hyper-activation of mTOR and STAT3 in leukocytes
por: Bezzerri, Valentino, et al.
Publicado: (2016)

Evaluation of eluforsen, a novel RNA oligonucleotide for restoration of CFTR function in in vitro and murine models of p.Phe508del cystic fibrosis
por: Beumer, Wouter, et al.
Publicado: (2019)

SFPQ rescues F508del-CFTR expression and function in cystic fibrosis bronchial epithelial cells
por: Kumar, Parameet, et al.
Publicado: (2021)

Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis
por: Esposito, Speranza, et al.
Publicado: (2016)

ΔF508 CFTR interactome remodeling promotes rescue of Cystic Fibrosis
por: Pankow, Sandra, et al.
Publicado: (2015)

P.F508del editing in cells from cystic fibrosis patients
por: Smirnikhina, Svetlana A., et al.
Publicado: (2020)

Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice
por: Sandri, Angela, et al.
Publicado: (2018)

Screening for F508del as a first step in the molecular diagnosis of cystic fibrosis,
por: Marson, Fernando Augusto de Lima, et al.
Publicado: (2013)

Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2018)

Olfactory dysfunction in people with cystic fibrosis with at least one copy of F508del
por: Beswick, Daniel M., et al.
Publicado: (2022)

PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis
por: Noel, Sabrina, et al.
Publicado: (2012)

Expression of ΔF508 Cystic Fibrosis Transmembrane Regulator (CFTR) Decreases Membrane Sialylation
por: Dosanjh, Amrita, et al.
Publicado: (2009)

Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation
por: Stefano, Daniela De, et al.
Publicado: (2014)

Elexacaftor–Tezacaftor–Ivacaftor Therapy for Cystic Fibrosis Patients with The F508del/Unknown Genotype
por: Comegna, Marika, et al.
Publicado: (2021)

On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis
por: Ensinck, Marjolein, et al.
Publicado: (2021)

Protein Tyrosine Phosphatase Gamma (PTPγ) is a Novel Leukocyte Marker Highly Expressed by CD34(+) Precursors
por: Mafficini, Andrea, et al.
Publicado: (2007)

Ouabain Mimics Low Temperature Rescue of F508del-CFTR in Cystic Fibrosis Epithelial Cells
por: Zhang, Donglei, et al.
Publicado: (2012)

Calpain Inhibition Promotes the Rescue of F(508)del-CFTR in PBMC from Cystic Fibrosis Patients
por: Averna, Monica, et al.
Publicado: (2013)

Ivacaftor and sinonasal pathology in a cystic fibrosis patient with genotype delta F508/S1215N
por: Berkhout, Maaike, et al.
Publicado: (2015)

Case report: Three adult brothers with cystic fibrosis (delF508-delF508) maintain unusually preserved clinical profile in the absence of standard CF care
por: Bishop, Clark T.
Publicado: (2021)

Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis
por: Boëlle, Pierre-Yves, et al.
Publicado: (2012)

PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients
por: Chiarini, M, et al.
Publicado: (2010)

Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors
por: Amico, Giulia, et al.
Publicado: (2019)

Integrative chemogenomic analysis identifies small molecules that partially rescue ΔF508‐CFTR for cystic fibrosis
por: Hodos, Rachel A., et al.
Publicado: (2021)

Correlations of MIF polymorphism and serum levels of MIF with glucocorticoid sensitivity of sudden sensorineural hearing loss
por: Zhu, Wen-Yan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bqm88tr9f8sm19e3qsdd7anhlg